Search Results

There are 10592 results for: content related to: Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions

  1. Infliximab for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Barbara BTB Blumenauer, Maria Judd, George A Wells, Amanda Burls, Ann Cranney, Marc C Hochberg, Peter Tugwell and Maria Angeles Lopez-Olivo

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD003785

  2. You have free access to this content
    Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab

    Arthritis & Rheumatism

    Volume 54, Issue 12, December 2006, Pages: 3782–3789, Klaus Bendtzen, Pierre Geborek, Morten Svenson, Lotta Larsson, Meliha C. Kapetanovic and Tore Saxne

    Version of Record online : 28 NOV 2006, DOI: 10.1002/art.22214

  3. You have free access to this content
    Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis

    British Journal of Clinical Pharmacology

    Volume 73, Issue 1, January 2012, Pages: 55–65, David Ternant, Denis Mulleman, Francine Lauféron, Céline Vignault, Emilie Ducourau, Daniel Wendling, Philippe Goupille and Gilles Paintaud

    Version of Record online : 8 DEC 2011, DOI: 10.1111/j.1365-2125.2011.04050.x

  4. Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 7, July 2012, Pages: 1199–1206, Benjamin Pariente, Guillaume Pineton de Chambrun, Roman Krzysiek, Marine Desroches, Gauthier Louis, Chiara De Cassan, Clotilde Baudry, Jean-Marc Gornet, Pierre Desreumaux, Dominique Emilie, Jean-Frédéric Colombel and Matthieu Allez

    Version of Record online : 29 AUG 2011, DOI: 10.1002/ibd.21839

  5. Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 7, October 2016, Pages: 673–683, T. Billiet, I. Cleynen, V. Ballet, M. Ferrante, G. Van Assche, A. Gils and S. Vermeire

    Version of Record online : 9 AUG 2016, DOI: 10.1111/apt.13754

  6. You have free access to this content
    Plasma trough levels of adalimumab and infliximab in terms of clinical efficacy during the treatment of psoriasis

    The Journal of Dermatology

    Volume 40, Issue 1, January 2013, Pages: 39–42, Hidetoshi Takahashi, Hitomi Tsuji, Akemi Ishida-Yamamoto and Hajime Iizuka

    Version of Record online : 5 OCT 2012, DOI: 10.1111/j.1346-8138.2012.01679.x

  7. You have free access to this content
    Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: Results from a randomized control study

    Arthritis Care & Research

    Volume 61, Issue 5, 15 May 2009, Pages: 569–576, Roman Krzysiek, Maxime Breban, Philippe Ravaud, Maria Vittoria Prejean, John Wijdenes, Carine Roy, Yves-Dominique Henry, Carole Barbey, Gérard Trappe, Maxime Dougados and Dominique Emilie

    Version of Record online : 29 APR 2009, DOI: 10.1002/art.24275

  8. You have free access to this content
    A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 56, Issue 9, September 2007, Pages: 3096–3106, Nicolino Ruperto, Daniel J. Lovell, Ruben Cuttica, Nick Wilkinson, Patricia Woo, Graciela Espada, Carine Wouters, Earl D. Silverman, Zsolt Balogh, Michael Henrickson, Maria-Teresa Apaz, Eileen Baildam, Anders Fasth, Valeria Gerloni, Pekka Lahdenne, Anne-Marie Prieur, Angelo Ravelli, Rotraud K. Saurenmann, Maria Luz Gamir, Nico Wulffraat, Laszlo Marodi, Ross E. Petty, Rik Joos, Francesco Zulian, Deborah McCurdy, Barry L. Myones, Kalman Nagy, Peter Reuman, Ilona Szer, Suzanne Travers, Anna Beutler, Greg Keenan, Jason Clark, Sudha Visvanathan, Adedigbo Fasanmade, Aparna Raychaudhuri, Alan Mendelsohn, Alberto Martini and Edward H. Giannini

    Version of Record online : 30 AUG 2007, DOI: 10.1002/art.22838

  9. You have free access to this content
    Costs of care for Crohn’s disease following the introduction of infliximab: a single-centre UK experience

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 11-12, December 2010, Pages: 1357–1363, M. B. Sprakes, A. C. Ford, N. C. Suares, L. Warren, D. Greer, C. F. Donnellan, J. S. R. Jennings, S. M. Everett and P. J. Hamlin

    Version of Record online : 6 OCT 2010, DOI: 10.1111/j.1365-2036.2010.04482.x

  10. Infliximab dependency in pediatric Crohn's disease: Long-term follow-up of an unselected cohort

    Inflammatory Bowel Diseases

    Volume 14, Issue 3, March 2008, Pages: 353–358, Lissy de Ridder, Edmond H.H.M. Rings, Gerard M. Damen, C.M. Frank Kneepkens, Joachim J. Schweizer, Freddy T.M. Kokke, Marc A. Benninga, Obbe F. Norbruis, J. Hans Hoekstra, Carolien F.M. Gijsbers and Johanna C. Escher

    Version of Record online : 10 DEC 2007, DOI: 10.1002/ibd.20329

  11. Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 6, November 2004, Pages: 801–810, Mihaela Ringheanu, Fredric Daum, James Markowitz, Jeremiah Levine, Seymour Katz, Xingyu Lin and Jack Silver

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200411000-00015

  12. You have free access to this content
    TNF-alpha inhibitors for ankylosing spondylitis

    Intervention Review

    The Cochrane Library

    Lara J Maxwell, Jane Zochling, Annelies Boonen, Jasvinder A Singh, Mirella MS Veras, Elizabeth Tanjong Ghogomu, Maria Benkhalti Jandu, Peter Tugwell and George A Wells

    Published Online : 18 APR 2015, DOI: 10.1002/14651858.CD005468.pub2

  13. Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction

    British Journal of Dermatology

    Volume 165, Issue 6, December 2011, Pages: 1355–1358, J.H.O. Hoffmann, M. Hartmann, A.H. Enk and E.N. Hadaschik

    Version of Record online : 17 NOV 2011, DOI: 10.1111/j.1365-2133.2011.10555.x

  14. You have free access to this content
    Infliximab Inhibits Activation and Effector Functions of Peripheral Blood T Cells in vitro from Patients with Clinically Active Ulcerative Colitis

    Scandinavian Journal of Immunology

    Volume 78, Issue 3, September 2013, Pages: 275–284, R. Dahlén, H. Strid, A. Lundgren, S. Isaksson, S. Raghavan, M. K. Magnusson, M. Simrén, H. Sjövall and L. Öhman

    Version of Record online : 22 AUG 2013, DOI: 10.1111/sji.12081

  15. You have free access to this content
    Infliximab therapy increases the frequency of circulating CD16+ monocytes and modifies macrophage cytokine response to bacterial infection

    Clinical & Experimental Immunology

    Volume 177, Issue 3, September 2014, Pages: 703–711, N. Nazareth, F. Magro, J. Silva, M. Duro, D. Gracio, R. Coelho, R. Appelberg, G. Macedo and A. Sarmento

    Version of Record online : 24 JUL 2014, DOI: 10.1111/cei.12375

  16. Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis

    The Journal of Clinical Pharmacology

    Volume 48, Issue 6, June 2008, Pages: 681–695, Zhenhua Xu, Kathleen Seitz, Adedigbo Fasanmade, Joyce Ford, Paul Williamson, Weichun Xu, Hugh M. Davis and Honghui Zhou

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008316886

  17. You have free access to this content
    Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three-month, randomized, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 48, Issue 8, August 2003, Pages: 2224–2233, J. Braun, J. Brandt, J. Listing, A. Zink, R. Alten, G. Burmester, W. Golder, E. Gromnica-Ihle, H. Kellner, M. Schneider, H. Sörensen, H. Zeidler, J. Reddig and J. Sieper

    Version of Record online : 1 AUG 2003, DOI: 10.1002/art.11104

  18. Biologics for rheumatoid arthritis: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Robin Christensen, George A Wells, Maria E Suarez-Almazor, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Elizabeth Tanjong Ghogomu and Peter Tugwell

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007848.pub2

  19. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 45, Issue 7, April 2017, Pages: 933–940, A. J. Yarur, V. Kanagala, D. J. Stein, F. Czul, M. A. Quintero, D. Agrawal, A. Patel, K. Best, C. Fox, K. Idstein and M. T. Abreu

    Version of Record online : 17 FEB 2017, DOI: 10.1111/apt.13970

  20. You have free access to this content
    A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 10, May 2014, Pages: 1126–1135, B. G. Levesque, G. R. Greenberg, G. Zou, W. J. Sandborn, S. Singh, S. Hauenstein, L. Ohrmund, C. J. Wong, L. W. Stitt, L. M. Shackelton, D. King, S. Lockton, J. Ducharme and B. G. Feagan

    Version of Record online : 1 APR 2014, DOI: 10.1111/apt.12733